alpha Synuclein-VC Citations (4)
Originally described in: Formation of toxic oligomeric alpha-synuclein species in living cells.Outeiro TF, Putcha P, Tetzlaff JE, Spoelgen R, Koker M, Carvalho F, Hyman BT, McLean PJ PLoS One. 2008 Apr 2;3(4):e1867. doi: 10.1371/journal.pone.0001867. PubMed Journal
Articles Citing alpha Synuclein-VC
| Articles |
|---|
| Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get. Frey B, AlOkda A, Jackson MP, Riguet N, Duce JA, Lashuel HA. J Neurochem. 2021 May;157(4):872-888. doi: 10.1111/jnc.15147. Epub 2020 Oct 27. PubMed |
Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson's disease-linked DNAJC6 mutations.
Wulansari N, Darsono WHW, Woo HJ, Chang MY, Kim J, Bae EJ, Sun W, Lee JH, Cho IJ, Shin H, Lee SJ, Lee SH.
Sci Adv. 2021 Feb 17;7(8). pii: 7/8/eabb1540. doi: 10.1126/sciadv.abb1540. Print 2021 Feb.
PubMed
Associated Plasmids |
| Cerebral dopamine neurotrophic factor reduces alpha-synuclein aggregation and propagation and alleviates behavioral alterations in vivo. Albert K, Raymundo DP, Panhelainen A, Eesmaa A, Shvachiy L, Araujo GR, Chmielarz P, Yan X, Singh A, Cordeiro Y, Palhano FL, Foguel D, Luk KC, Domanskyi A, Voutilainen MH, Huttunen HJ, Outeiro TF, Saarma M, Almeida MS, Airavaara M. Mol Ther. 2021 Sep 1;29(9):2821-2840. doi: 10.1016/j.ymthe.2021.04.035. Epub 2021 May 1. PubMed |
| S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote alpha-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia. Oh CK, Dolatabadi N, Cieplak P, Diaz-Meco MT, Moscat J, Nolan JP, Nakamura T, Lipton SA. J Neurosci. 2022 Apr 6;42(14):3011-3024. doi: 10.1523/JNEUROSCI.1508-21.2022. Epub 2022 Feb 15. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.